| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Article |
Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois
Abstract
Abstract I. Introduction A. The Aromatase Enzyme B. The Aromatase (CYP19) Gene C. Physiologic Regulation of Aromatase Expression in Human Tissues D. Pathology Related to Aromatase Overexpression II. Aromatase and Breast Cancer A. Estrogen Formation in Breast Cancer 1. Aromatase in Adipose Tissue and Skin: Endocrine Effect. 2. Local Aromatase in Breast Cancer Tissue: Paracrine/Intracrine Effect. B. Cellular Mechanisms That Regulate Aromatase Expression in Normal and Malignant Breast Tissue 1. Cellular Localization of Aromatase in Breast Cancer. 2. Inhibition of Adipogenic Differentiation in Breast Cancer: Link to Aromatase Overexpression. C. Molecular Mechanisms Responsible for Elevated Aromatase Expression in Breast Cancer 1. Up-Regulation of Promoters I.3 and II. 2. Regulation of Promoters II and I.3 in MCF7 Cells. 3. Up-Regulation of Promoter I.7 in Breast Cancer. D. Summary of Regulation of Aromatase Expression in Breast Cancer E. Aromatase Inhibitors in the Treatment of Breast Cancer III. Aromatase and Endometriosis A. Mechanisms of Growth and Inflammation in Endometriosis B. Definitions of Experimental Models and Abnormal Tissues in Women with Endometriosis C. Estrogen Formation in Endometriosis D. Cellular Mechanisms That Regulate Aromatase Expression in Eutopic Endometrium and Endometriosis E. Prostaglandin E2 Biosynthesis and Action in Endometriosis 1. Prostaglandin E2 Biosynthesis in Endometrial Disease. 2. Prostaglandin E2 Action on Endometriotic and Endometrial Stromal Cells. F. Molecular Mechanisms Responsible for Increased Expression of Steroidogenic Genes in Endometriosis 1. Up-Regulation of Promoter II for Increased Aromatase Expression. 2. Transcriptional Mechanisms Responsible for Increased Expression of the Aromatase Gene in Endometriosis. G. Activation of Multiple Steroidogenic Promoters in Endometriosis H. Summary of Regulation of Promoter II in Endometriotic Stromal Cells and Breast Adipose Fibroblasts I. Aromatase Inhibitors in the Treatment of Endometriosis IV. Aromatase and Endometrial Cancer V. Aromatase and Uterine Fibroids (Leiomyomata) A. Molecular Basis for Estrogen Dependence of Uterine Leiomyomata for Growth B. Regulation of Estrogen Biosynthesis in Leiomyoma Smooth Muscle Cells C. Aromatase Expression in Uterine Leiomyoma Tissues D. Regulation of Aromatase Expression in Leiomyoma Tissues and Smooth Muscle Cells E. Treatment of Uterine Leiomyomata with Aromatase Inhibitors VI. Aromatase Excess Syndrome A. Background and Clinical Manifestations B. Genetic Basis for Familial Aromatase Excess Syndrome C. Discussion on Gain-of-Function Mutations That Affect the Aromatase Gene VII. Conclusions Regarding Aromatase Overexpression in Estrogen-Dependent Human Disease
A single gene encodes the key enzyme for estrogen biosynthesis termed aromatase, inhibition of which effectively eliminates estrogen production. Aromatase inhibitors successfully treat breast cancer and endometriosis, whereas their roles in endometrial cancer, uterine fibroids, and aromatase excess syndrome are less clear. Ovary, testis, adipose tissue, skin, hypothalamus, and placenta express aromatase normally, whereas breast and endometrial cancers, endometriosis, and uterine fibroids overexpress aromatase and produce local estrogen that exerts paracrine and intracrine effects. Tissue-specific promoters distributed over a 93-kilobase regulatory region upstream of a common coding region alternatively control aromatase expression. A distinct set of transcription factors regulates each promoter in a signaling pathway- and tissue-specific manner. Three mechanisms are responsible for aromatase overexpression in a pathologic tissue versus its normal counterpart. First, cellular composition is altered to increase aromatase-expressing cell types that use distinct promoters (breast cancer). Second, molecular alterations in stromal cells favor binding of transcriptional enhancers versus inhibitors to a normally quiescent aromatase promoter and initiate transcription (breast/endometrial cancer, endometriosis, and uterine fibroids). Third, heterozygous mutations, which cause the aromatase coding region to lie adjacent to constitutively active cryptic promoters that normally transcribe other genes, result in excessive estrogen formation owing to the overexpression of aromatase in many tissues.
This article has been cited by other articles:
|
|
 |
|
  S.-W. Guo Recurrence of endometriosis and its control Hum. Reprod. Update, July 1, 2009; 15(4): 441 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, R. Li, and Y. Hu The Alternative Noncoding Exons 1 of Aromatase (Cyp19) Gene Modulate Gene Expression in a Posttranscriptional Manner Endocrinology, July 1, 2009; 150(7): 3301 - 3307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Odawara, T. Iwasaki, J. Horiguchi, N. Rokutanda, K. Hirooka, W. Miyazaki, Y. Koibuchi, N. Shimokawa, Y. Iino, I. Takeyoshi, et al. Activation of Aromatase Expression by Retinoic Acid Receptor-related Orphan Receptor (ROR) {alpha} in Breast Cancer Cells: IDENTIFICATION OF A NOVEL ROR RESPONSE ELEMENT J. Biol. Chem., June 26, 2009; 284(26): 17711 - 17719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Colette, J.C. Lousse, S. Defrere, M. Curaba, J.F. Heilier, A. Van Langendonckt, M. Mestdagt, J.M. Foidart, E. Loumaye, and J. Donnez Absence of aromatase protein and mRNA expression in endometriosis Hum. Reprod., June 2, 2009; (2009) dep199v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Guo, L. Hummelshoj, D. L. Olive, S. E. Bulun, T. M. D'Hooghe, and J. L.H. Evers A call for more transparency of registered clinical trials on endometriosis Hum. Reprod., June 1, 2009; 24(6): 1247 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghosh, A. Choudary, S. Ghosh, N. Musi, Y. Hu, and R. Li IKK{beta} Mediates Cell Shape-Induced Aromatase Expression and Estrogen Biosynthesis in Adipose Stromal Cells Mol. Endocrinol., May 1, 2009; 23(5): 662 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ishikawa, S. Reierstad, M. Demura, A. W. Rademaker, T. Kasai, M. Inoue, H. Usui, M. Shozu, and S. E. Bulun High Aromatase Expression in Uterine Leiomyoma Tissues of African-American Women J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1752 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Trukhacheva, Z. Lin, S. Reierstad, Y.-H. Cheng, M. Milad, and S. E. Bulun Estrogen Receptor (ER) {beta} Regulates ER{alpha} Expression in Stromal Cells Derived from Ovarian Endometriosis J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 615 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Bulun Endometriosis N. Engl. J. Med., January 15, 2009; 360(3): 268 - 279. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Van Voorhis A 41-Year-Old Woman With Menorrhagia, Anemia, and Fibroids: Review of Treatment of Uterine Fibroids JAMA, January 7, 2009; 301(1): 82 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Demura, S. Reierstad, J. E. Innes, and S. E. Bulun Novel Promoter I.8 and Promoter Usage in the CYP19 (Aromatase) Gene Reproductive Sciences, December 1, 2008; 15(10): 1044 - 1053. [Abstract] [PDF]
|
|
|
|
|
|
O. Bukulmez, D. B. Hardy, B. R. Carr, R. J. Auchus, T. Toloubeydokhti, R. A. Word, and C. R. Mendelson Androstenedione Up-Regulation of Endometrial Aromatase Expression via Local Conversion to Estrogen: Potential Relevance to the Pathogenesis of Endometriosis J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3471 - 3477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsujikawa, Y. Yoshida, T. Mori, T. Kurokawa, Y. Fujibayashi, F. Kotsuji, and H. Okazawa Uterine Tumors: Pathophysiologic Imaging with 16{alpha}-[18F]fluoro-17{beta}-estradiol and 18F Fluorodeoxyglucose PET--Initial Experience Radiology, August 1, 2008; 248(2): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Huang, S.-H. Kuo, H.-C. Lien, S.-Y. Yang, S.-L. You, C.-Y. Shen, C.-H. Lin, Y.-S. Lu, and K.-J. Chang The CYP19 TTTA Repeat Polymorphism Is Related to the Prognosis of Premenopausal Stage I-II and Operable Stage III Breast Cancers Oncologist, July 1, 2008; 13(7): 751 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Matsumoto, Y. Yamaguchi, Y. Seino, A. Hatakeyama, H. Takei, H. Niikura, K. Ito, T. Suzuki, H. Sasano, N. Yaegashi, et al. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction Endocr. Relat. Cancer, June 1, 2008; 15(2): 451 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Utsunomiya, Y.-H. Cheng, Z. Lin, S. Reierstad, P. Yin, E. Attar, Q. Xue, G. Imir, S. Thung, E. Trukhacheva, et al. Upstream Stimulatory Factor-2 Regulates Steroidogenic Factor-1 Expression in Endometriosis Mol. Endocrinol., April 1, 2008; 22(4): 904 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rajhans, H. B. Nair, S. S. Nair, V. Cortez, K. Ikuko, N. B. Kirma, D. Zhou, A. E. Holden, D. W Brann, S. Chen, et al. Modulation of in Situ Estrogen Synthesis by Proline-, Glutamic Acid-, and Leucine-Rich Protein-1: Potential Estrogen Receptor Autocrine Signaling Loop in Breast Cancer Cells Mol. Endocrinol., March 1, 2008; 22(3): 649 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishikawa, V. Fencki, E. E. Marsh, P. Yin, D. Chen, Y.-H. Cheng, S. Reisterd, Z. Lin, and S. E. Bulun CCAAT/Enhancer Binding Protein {beta} Regulates Aromatase Expression via Multiple and Novel Cis-Regulatory Sequences in Uterine Leiomyoma J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 981 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis Endocrinology, March 1, 2008; 149(3): 1190 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Subbaramaiah, C. Hudis, S.-H. Chang, T. Hla, and A. J. Dannenberg EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells: EVIDENCE OF A BRCA1 AND p300 EXCHANGE J. Biol. Chem., February 8, 2008; 283(6): 3433 - 3444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hudelist, K. Czerwenka, J. Keckstein, C. Haas, A. Fink-Retter, D. Gschwantler-Kaulich, E. Kubista, and C.F. Singer Expression of Aromatase and Estrogen Sulfotransferase in Eutopic and Ectopic Endometrium: Evidence for Unbalanced Estradiol Production in Endometriosis Reproductive Sciences, December 1, 2007; 14(8): 798 - 805. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Demura, R. M. Martin, M. Shozu, S. Sebastian, K. Takayama, W.-T. Hsu, R. A. Schultz, K. Neely, M. Bryant, B. B. Mendonca, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene Hum. Mol. Genet., November 1, 2007; 16(21): 2529 - 2541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xue, Z. Lin, Y.-H. Cheng, C.-C. Huang, E. Marsh, P. Yin, M. P Milad, E. Confino, S. Reierstad, J. Innes, et al. Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis Biol Reprod, October 1, 2007; 77(4): 681 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts Cancer Res., September 15, 2007; 67(18): 8914 - 8922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Xue, Z. Lin, P. Yin, M. P. Milad, Y.-H. Cheng, E. Confino, S. Reierstad, and S. E. Bulun Transcriptional Activation of Steroidogenic Factor-1 by Hypomethylation of the 5' CpG Island in Endometriosis J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3261 - 3267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zang, L. Sahlin, B. Masironi, E. Eriksson, and A. Linden Hirschberg Effects of Testosterone Treatment on Endometrial Proliferation in Postmenopausal Women J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2169 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Imir, Z. Lin, P. Yin, S. Deb, B. Yilmaz, M. Cetin, A. Cetin, and S. E. Bulun Aromatase Expression in Uterine Leiomyomata Is Regulated Primarily by Proximal Promoters I.3/II J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1979 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lu, D. Chen, Z. Lin, S. Reierstad, A. M. Trauernicht, T. G. Boyer, and S. E. Bulun BRCA1 Negatively Regulates the Cancer-Associated Aromatase Promoters I.3 and II in Breast Adipose Fibroblasts and Malignant Epithelial Cells J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4514 - 4519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Sherman, J. V. Lacey, S. S. Buys, D. J. Reding, C. D. Berg, C. Williams, and P. Hartge Ovarian Volume: Determinants and Associations with Cancer among Postmenopausal Women. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1550 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.K. Welt, Y. Jimenez, P.M. Sluss, P.C. Smith, and J.E. Hall Control of estradiol secretion in reproductive ageing Hum. Reprod., August 1, 2006; 21(8): 2189 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Deb, J. Zhou, S. A. Amin, A. G. Imir, M. B. Yilmaz, Z. Lin, and S. E. Bulun A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts J. Biol. Chem., February 3, 2006; 281(5): 2585 - 2597. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
 |
 |
 |
|
 |
 |
 |
